There are a number of creative ways for defendants to challenge master complaints in MDLs.

The revisions would significantly limit safe harbor provisions that protect against bounty hunters.

Our US medical system continues to put the physician between the medication or treatment and the patient for a reason.

The Albrecht decision clarifies and substantially narrows the scope of preemption under the Wyeth v. Levine “clear evidence” standard.

Medical device manufacturers should take this opportunity to assess their compliance with HIPAA and FDA’s Draft Guidance, then complete a Risk Management Plan.

A look at four of the most pressing, high-profile issues facing the new acting FDA commissioner.

The ruling significantly strengthens preemption law in two respects.

This data hunt will affect thousands of facilities, drinking water systems and private drinking water well owners.